What is the mechanism of action of epinephrine 1:1000?

Study for the Massachusetts OEMS BLS Test. Gain confidence with multiple-choice questions and detailed explanations. Prepare effectively for your exam!

Multiple Choice

What is the mechanism of action of epinephrine 1:1000?

Explanation:
Epinephrine 1:1000 works by nonselectively activating both alpha and beta adrenergic receptors. Activation of alpha-1 receptors on vascular smooth muscle causes vasoconstriction, which raises blood pressure and reduces mucosal edema in the airways. Activation of beta-1 receptors in the heart increases heart rate and the force of contraction, boosting cardiac output. Activation of beta-2 receptors in bronchial smooth muscle produces bronchodilation, easing bronchospasm. When given intramuscularly for anaphylaxis, these combined effects rapidly counter airway compromise and hypotension. The described actions—vasoconstriction, increased heart rate/contractility, and bronchodilation—fit the mechanism of epinephrine best, whereas the other options describe effects epinephrine does not primarily produce (vasodilation with bradycardia, platelet aggregation inhibition, or acetylcholine receptor blockade).

Epinephrine 1:1000 works by nonselectively activating both alpha and beta adrenergic receptors. Activation of alpha-1 receptors on vascular smooth muscle causes vasoconstriction, which raises blood pressure and reduces mucosal edema in the airways. Activation of beta-1 receptors in the heart increases heart rate and the force of contraction, boosting cardiac output. Activation of beta-2 receptors in bronchial smooth muscle produces bronchodilation, easing bronchospasm. When given intramuscularly for anaphylaxis, these combined effects rapidly counter airway compromise and hypotension. The described actions—vasoconstriction, increased heart rate/contractility, and bronchodilation—fit the mechanism of epinephrine best, whereas the other options describe effects epinephrine does not primarily produce (vasodilation with bradycardia, platelet aggregation inhibition, or acetylcholine receptor blockade).

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy